Indirect competitive enzyme-linked immunosorbent assay (ELISA) for the determination of mammalian gelatin in pharmaceutical capsules

Gelatin is derived from partial hydrolysis of type I collagen (connective tissues such as skin, bone, tendon, and ligament), which is commonly obtained from mammalian sources (porcine and bovine). However, the use of gelatin derived from mammalian sources in pharmaceutical products have become a con...

Full description

Bibliographic Details
Main Authors: Tukiran, Nur Azira, Ismail, Amin, Mustafa, Shuhaimi, Hamid, Muhajir
Format: Conference or Workshop Item
Language:English
Published: Springer 2018
Subjects:
Online Access:http://irep.iium.edu.my/68682/
http://irep.iium.edu.my/68682/
http://irep.iium.edu.my/68682/
http://irep.iium.edu.my/68682/1/Paper%20IHAC%202018.pdf
id iium-68682
recordtype eprints
spelling iium-686822019-07-15T03:13:41Z http://irep.iium.edu.my/68682/ Indirect competitive enzyme-linked immunosorbent assay (ELISA) for the determination of mammalian gelatin in pharmaceutical capsules Tukiran, Nur Azira Ismail, Amin Mustafa, Shuhaimi Hamid, Muhajir Q Science (General) Q128 Islam and Science QD Chemistry Gelatin is derived from partial hydrolysis of type I collagen (connective tissues such as skin, bone, tendon, and ligament), which is commonly obtained from mammalian sources (porcine and bovine). However, the use of gelatin derived from mammalian sources in pharmaceutical products have become a controversial issue regarding religious and health concern. Thus, the aim of this study was to develop indirect competitive enzyme-linked immunosorbent assays (ELISAs) based on antipeptide polyclonal antibodies (pAbs) for the determination of mammalian gelatin in pharmaceutical capsules. Polyclonal antibodies against amino acid sequences of collagen α2 (I) chain were used (pAb1 and pAb2). The IC50 value of 0.390 µg/mL and detection limit of 0.082 µg/mL (in buffer) were achieved by ELISA based on pAb2. The intra-assay (<14%) and inter-assay (<13%) coefficients of variation were also acceptable. The ELISA was successfully applied for the determination of mammalian gelatin in pharmaceutical capsule (hard shell capsule, soft shell capsule, and tablet). The result suggests that this ELISA method is useful for determination of mammalian gelatin in selected pharmaceutical capsules. Springer 2018 Conference or Workshop Item PeerReviewed application/pdf en http://irep.iium.edu.my/68682/1/Paper%20IHAC%202018.pdf Tukiran, Nur Azira and Ismail, Amin and Mustafa, Shuhaimi and Hamid, Muhajir (2018) Indirect competitive enzyme-linked immunosorbent assay (ELISA) for the determination of mammalian gelatin in pharmaceutical capsules. In: 3rd International Halal Conference (INHAC 2016), 21st-22nd November 2016, Shah Alam, Selangor. https://link.springer.com/chapter/10.1007/978-981-10-7257-4_38 10.1007/978-981-10-7257-4_38
repository_type Digital Repository
institution_category Local University
institution International Islamic University Malaysia
building IIUM Repository
collection Online Access
language English
topic Q Science (General)
Q128 Islam and Science
QD Chemistry
spellingShingle Q Science (General)
Q128 Islam and Science
QD Chemistry
Tukiran, Nur Azira
Ismail, Amin
Mustafa, Shuhaimi
Hamid, Muhajir
Indirect competitive enzyme-linked immunosorbent assay (ELISA) for the determination of mammalian gelatin in pharmaceutical capsules
description Gelatin is derived from partial hydrolysis of type I collagen (connective tissues such as skin, bone, tendon, and ligament), which is commonly obtained from mammalian sources (porcine and bovine). However, the use of gelatin derived from mammalian sources in pharmaceutical products have become a controversial issue regarding religious and health concern. Thus, the aim of this study was to develop indirect competitive enzyme-linked immunosorbent assays (ELISAs) based on antipeptide polyclonal antibodies (pAbs) for the determination of mammalian gelatin in pharmaceutical capsules. Polyclonal antibodies against amino acid sequences of collagen α2 (I) chain were used (pAb1 and pAb2). The IC50 value of 0.390 µg/mL and detection limit of 0.082 µg/mL (in buffer) were achieved by ELISA based on pAb2. The intra-assay (<14%) and inter-assay (<13%) coefficients of variation were also acceptable. The ELISA was successfully applied for the determination of mammalian gelatin in pharmaceutical capsule (hard shell capsule, soft shell capsule, and tablet). The result suggests that this ELISA method is useful for determination of mammalian gelatin in selected pharmaceutical capsules.
format Conference or Workshop Item
author Tukiran, Nur Azira
Ismail, Amin
Mustafa, Shuhaimi
Hamid, Muhajir
author_facet Tukiran, Nur Azira
Ismail, Amin
Mustafa, Shuhaimi
Hamid, Muhajir
author_sort Tukiran, Nur Azira
title Indirect competitive enzyme-linked immunosorbent assay (ELISA) for the determination of mammalian gelatin in pharmaceutical capsules
title_short Indirect competitive enzyme-linked immunosorbent assay (ELISA) for the determination of mammalian gelatin in pharmaceutical capsules
title_full Indirect competitive enzyme-linked immunosorbent assay (ELISA) for the determination of mammalian gelatin in pharmaceutical capsules
title_fullStr Indirect competitive enzyme-linked immunosorbent assay (ELISA) for the determination of mammalian gelatin in pharmaceutical capsules
title_full_unstemmed Indirect competitive enzyme-linked immunosorbent assay (ELISA) for the determination of mammalian gelatin in pharmaceutical capsules
title_sort indirect competitive enzyme-linked immunosorbent assay (elisa) for the determination of mammalian gelatin in pharmaceutical capsules
publisher Springer
publishDate 2018
url http://irep.iium.edu.my/68682/
http://irep.iium.edu.my/68682/
http://irep.iium.edu.my/68682/
http://irep.iium.edu.my/68682/1/Paper%20IHAC%202018.pdf
first_indexed 2023-09-18T21:37:27Z
last_indexed 2023-09-18T21:37:27Z
_version_ 1777412915774619648